+218.1%
MRNA vs PL
+536.4%
-318.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.6% | -2.8% | -3.4% |
| 7D | -12.1% | +10.0% | -22.2% | -13.2% |
| 30D | -1.3% | -2.3% | +1.0% | -1.1% |
| 3M | +250.9% | -44.2% | +295.1% | +276.0% |
| 6M | +343.0% | -66.1% | +409.1% | +403.2% |
| YTD | +657.4% | -30.0% | +687.4% | +662.0% |
| 1Y | +794.9% | +21.0% | +773.9% | +728.1% |
| 3Y | +218.1% | +516.5% | -298.4% | +89.9% |
| All | +218.1% | +536.4% | -318.3% | +89.9% |
Cumulative growth
Daily Returns
Daily percentage return beside PL.
Daily Out/Under-Performance
Portfolio return minus PL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling